✓ Translated by DotMD AI Clinical Council Source: Menopause (New York, N.Y.) • Meta-Analysis
Verify Primary Source: NIH PubMed PMID #35102100 ↗

Meta-Analysis: Different regimens of menopausal hormone therapy for improving sleep quality

Original Paper Title: “Different regimens of menopausal hormone therapy for improving sleep quality: a systematic review and meta-analysis”

Elena Rostova (AI Quant) Rigor Score
92 / 100
Sample Size (Participants)
Systematic Review
Evidence Classification
Meta-Analysis
Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways
  • We identified a total of 3,059 studies and finally included 15 studies in the meta-analysis. Compared with placebo, HT improved self-reported sleep outcomes (SMD = -0.13; 95% CI, -0.18 to -0.08, P < 0.00001 and I2 = 41%), but not sleep parameters measured by polysomnography.
  • Study Design & Sample: Meta-Analysis published in Menopause (New York, N.Y.) (Multi-cohort synthesis).
  • Biostatistical Rigor Score: 92/100 audited by Elena Rostova (AI Biostatistician & openFDA Quant).

What the Study Found (In Plain English)

Published in Menopause (New York, N.Y.) (2022), this meta-analysis evaluating human clinical outcomes investigated: We did a systematic review and meta-analysis to assess the effects of different HT regimens on menopausal sleep quality. Key clinical takeaway: We identified a total of 3,059 studies and finally included 15 studies in the meta-analysis. Compared with placebo, HT improved self-reported sleep outcomes (SMD = -0.13; 95% CI, -0.18 to -0.08, P < 0.00001 and I2 = 41%), but not sleep parameters measured by polysomnography.

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Primary Endpoint & Quantitative Summary (Menopause (New York, N.Y.), 2022-05-01; Meta-Analysis; Rigor 92/100): We identified a total of 3,059 studies and finally included 15 studies in the meta-analysis. Compared with placebo, HT improved self-reported sleep outcomes (SMD = -0.13; 95% CI, -0.18 to -0.08, P < 0.00001 and I2 = 41%), but not sleep parameters measured by polysomnography.

Study Limitations & Caveats Before You Act

Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Meta-Analysis). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.

Related DotMD Clinical Hubs & Price Ledgers

Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID 35102100: Meta-Analysis: Different regimens of menopausal hormone therapy for improving sleep quality

3 of 3 Free Questions Remaining